Preferred Label : linzagolix;

MeSH synonym : 3-(5-((2,3-difluoro-6-methoxyphenyl)methoxy)-2-fluoro-4-methoxyphenyl)-2,4-dioxo-1H-thieno(3,4-d)pyrimidine-5-carboxylic acid;

MeSH hyponym : KLH-2109; OBE2109;

UNII : 7CDW97HUEX;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


https://www.has-sante.fr/jcms/p_3490827/fr/yselty-linzagolix-choline-fibromes-uterins
2024
false
false
false
France
administration, oral
adult
linzagolix
receptors, LHRH
evaluation of the transparency committee
Linzagolix Choline
fibroid uterus
linzagolix
leiomyoma

---
https://www.ema.europa.eu/en/medicines/human/EPAR/yselty
2022
false
false
false
Netherlands
French
English
Linzagolix Choline
Linzagolix Choline
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
linzagolix
drug approval
europe
adult
leiomyoma
administration, oral
drug therapy, combination
pregnancy
breast feeding
drug interactions
Gonadotropin releasing hormone receptor antagonist (disposition)
receptors, LHRH
linzagolix
product surveillance, postmarketing
drug evaluation, preclinical

---
Nous contacter.
27/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.